278 related articles for article (PubMed ID: 27357191)
1. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
2. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Tan YV; Abad C; Wang Y; Lopez R; Waschek J
Brain Behav Immun; 2015 Feb; 44():167-175. PubMed ID: 25305591
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.
Abad C; Tan YV; Lopez R; Nobuta H; Dong H; Phan P; Feng JM; Campagnoni AT; Waschek JA
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19555-60. PubMed ID: 20978211
[TBL] [Abstract][Full Text] [Related]
4. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
5. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
6. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.
Graham KL; Zabel BA; Loghavi S; Zuniga LA; Ho PP; Sobel RA; Butcher EC
J Immunol; 2009 Nov; 183(10):6717-23. PubMed ID: 19864606
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.
Zaheer S; Wu Y; Sahu SK; Zaheer A
Neurobiol Dis; 2010 Dec; 40(3):593-8. PubMed ID: 20696246
[TBL] [Abstract][Full Text] [Related]
9. Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.
Ji Z; Fan Z; Zhang Y; Yu R; Yang H; Zhou C; Luo J; Ke ZJ
J Immunol; 2014 Sep; 193(5):2157-67. PubMed ID: 25063874
[TBL] [Abstract][Full Text] [Related]
10. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
11. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis.
Tan YV; Abad C; Lopez R; Dong H; Liu S; Lee A; Gomariz RP; Leceta J; Waschek JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2012-7. PubMed ID: 19190179
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor.
Zaheer S; Wu Y; Yang X; Ahrens M; Sahu SK; Zaheer A
Neurochem Int; 2012 Feb; 60(3):215-9. PubMed ID: 22226840
[TBL] [Abstract][Full Text] [Related]
14. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
15. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
17. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in EAE reveal common and distinct cellular and molecular components.
Wiedrick J; Meza-Romero R; Gerstner G; Seifert H; Chaudhary P; Headrick A; Kent G; Maestas A; Offner H; Vandenbark AA
Cell Immunol; 2021 Jan; 359():104242. PubMed ID: 33190849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
